Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on April 22, 2014, to announce its first-quarter financial results for the period ending March 31, 2014. The report primarily directs investors to a press release (Exhibit 99.1) containing detailed financial information, including both GAAP and non-GAAP figures. Management emphasizes the usefulness of non-GAAP metrics for understanding operational performance, as these are used internally for planning and budgeting. While the 8-K itself does not contain the specific financial figures, it confirms the release of these results and highlights Gilead's practice of providing supplemental non-GAAP information. Investors are encouraged to review the attached press release for a comprehensive understanding of the company's financial condition and results of operations for the quarter, including reconciliations between GAAP and non-GAAP measures.
Key Highlights
- 1Gilead Sciences announced its Q1 2014 financial results on April 22, 2014.
- 2The results are detailed in a press release filed as Exhibit 99.1 to the 8-K.
- 3Gilead presented both GAAP and non-GAAP financial information for the quarter.
- 4Management believes non-GAAP figures offer useful insights for investors and are used internally for operational planning.
- 5A reconciliation between GAAP and non-GAAP financial data is available in the press release.
- 6The information furnished in the 8-K and exhibit is not considered 'filed' for certain SEC liabilities.